Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Nov-23 2:46 PM View:  | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition | 26,585 | $19.00 | $505,115.00 | (61%) 43.29K to 16.71K | |
| 13-Nov-23 2:46 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 16,706 | $19.00 | $317,414.00 | (100%) 16.71K to 0 | |
| 16-Feb-23 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 14-Feb-23 | Payment of Exercise | 386 | $21.21 | $8,187.06 | (< 1%) 43.68K to 43.29K | |
| 31-Jan-23 4:05 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Jan-23 | Grant | 12,200 | -- | -- | 39% 31.48K to 43.68K | |
| 03-Jan-23 4:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-22 | Payment of Exercise | 1,600 | $12.37 | $19,792.00 | (5%) 33.08K to 31.48K | |
| 06-Sep-22 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Sep-22 | Payment of Exercise | 597 | $18.06 | $10,781.80 | (2%) 33.67K to 33.08K | |
| 17-Aug-22 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-Aug-22 | Payment of Exercise | 124 | $18.19 | $2,255.56 | (< 1%) 33.8K to 33.67K | |
| 17-May-22 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-May-22 | Payment of Exercise | 124 | $17.88 | $2,217.12 | (< 1%) 33.92K to 33.8K | |
| 17-Feb-22 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-Feb-22 | Payment of Exercise | 171 | $15.93 | $2,724.03 | (< 1%) 34.09K to 33.92K | 6% |
| 15-Feb-22 4:48 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 14-Feb-22 | Payment of Exercise | 529 | $14.85 | $7,855.65 | (2%) 34.62K to 34.09K | (1%) |
| 31-Jan-22 4:15 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 27-Jan-22 | Grant | 10,300 | -- | -- | 42% 24.32K to 34.62K | |
| 04-Jan-22 4:19 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-21 | Payment of Exercise | 1,211 | $16.29 | $19,727.20 | (5%) 25.53K to 24.32K | (5%) |
| 17-Nov-21 7:00 AM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-Nov-21 | Payment of Exercise | 171 | $17.67 | $3,021.57 | (< 1%) 25.7K to 25.53K | (2%) |
| 03-Sep-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Sep-21 | Payment of Exercise | 820 | $15.05 | $12,341.00 | (3%) 26.52K to 25.7K | (< 1%) |
| 16-Aug-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-Aug-21 | Payment of Exercise | 171 | $14.92 | $2,551.32 | (< 1%) 26.7K to 26.52K | 0% |
| 17-May-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-May-21 | Payment of Exercise | 171 | $18.15 | $3,103.65 | (< 1%) 26.87K to 26.7K | 0% |
| 17-Feb-21 7:04 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-Feb-21 | Grant | 5,531 | -- | -- | 26% 21.34K to 26.87K | |
| 15-May-18 1:42 PM View: | Chimerix, Inc. (CMRX) | 14-May-18 | Payment of Exercise | 4,545 | $4.66 | $21,199.20 | (8%) 58.71K to 54.16K | (81%) |
| 05-Feb-18 7:44 PM View: | Chimerix, Inc. (CMRX) | 02-Feb-18 | Payment of Exercise | 2,290 | $4.67 | $10,690.60 | (4%) 61.0K to 58.71K | (81%) |
| 05-Dec-17 2:08 PM View: | Chimerix, Inc. (CMRX) | 01-Dec-17 | Market Sale | 19,833 | $4.47 | $88,673.30 | (25%) 80.83K to 61.0K | (89%) |
| 16-May-17 5:45 PM View: | Chimerix, Inc. (CMRX) | 12-May-17 | Payment of Exercise | 10,167 | $4.68 | $47,577.50 | (11%) 91.0K to 80.83K | (81%) |
| 26-Jan-17 5:46 PM View: | Chimerix, Inc. (CMRX) | 24-Jan-17 | Grant | 30,375 | -- | -- | 50% 60.62K to 91.0K | |
| 11-May-16 5:14 PM View: | Chimerix, Inc. (CMRX) | 09-May-16 | Grant | 60,000 | -- | -- | 9662% 0.62K to 60.62K |